Bayer Healthcare Pharmaceuticals Inc. v. Watson Pharmaceuticals, Inc. et al

Filing 382

ORDER Denying the Portion of 366 Watson's Emergency Motion to Stay as Moot. Signed by Judge Kent J. Dawson on 03/08/2013. (Copies have been distributed pursuant to the NEF - AC)

1
2
3
4
5

Michael D. Rounds (Nevada Bar # 4734)
Ryan E. Johnson (Nevada Bar # 9070)
WATSON ROUNDS
777 N. Rainbow Blvd., Suite 350
Las Vegas, NV 89107
[phone] (phone)
[phone] (facsimile)
[e-mail]
[e-mail]

Cedric C.Y. Tan (admitted pro hac vice)
Kristin M. Cooklin (admitted pro hac vice)
Neil McCarthy (admitted pro hac vice)
CROWELL & MORING LLP
1001 Pennsylvania Avenue, NW
Washington, DC 20004
[e-mail]
[e-mail]

6
7
8
9
10
11

Mark T. Jansen (admitted pro hac vice)
CROWELL & MORING LLP
275 Battery Street, 23rd Floor
San Francisco, CA 94111
[e-mail]
Counsel for Defendants/CounterclaimPlaintiffs Watson Pharmaceuticals, Inc. and
Watson Laboratories, Inc.

12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

UNITED STATES DISTRICT COURT
DISTRICT OF NEVADA
__________________________________________
BAYER SCHERING PHARMA AG
) No. 2:08-cv-00995-KJD-(GWF)
and BAYER HEALTHCARE
) Consolidated with
PHARMACEUTICALS INC.,
) No. 2:07-cv-01472-KJD-(GWF)
)
Plaintiffs/Counter-Defendants,
)
)
v.
)
) ORDER DENYING AS MOOT
) THE PORTION OF WATSON’S
) EMERGENCY MOTION TO STAY
) REQUESTING ALTERNATIVE RELIEF
WATSON PHARMACEUTICALS, INC.
) UNDER FED. R. CIV. P. RULE 60(b)(6)
and WATSON LABORATORIES, INC.,
)
)
Defendants/Counter-Plaintiffs,
)
and
)
)
SANDOZ INC.,
)
)
Defendant/Counter-Plaintiff.
)
__________________________________________)

1
2
3
4
5

On February 11, 2013, this Court granted Plaintiff’s Motion to Reset the Effective Date of
the FDA’s approval for the Defendants to Market Generic YAZ. (Dkt. 363.)
On February 12, 2013, Defendant Sandoz Inc. (“Sandoz”) filed an emergency motion to stay
the Court’s February 11 order (see Dkt. 364.) and a memorandum in support thereof (“Emergency
Motion to Stay”). Sandoz requested relief therein pursuant to Fed. R. Civ. P. 62(c) (Dkt. 364 at 2.)

6
7
8
9
10
11
12

and, in the alternative, pursuant to Fed. R. Civ. P. 60(b)(6).
On February 13, 2013 Defendants Watson Pharmaceuticals, Inc. and Watson Laboratories,
Inc. (collectively, “Watson”) filed a joinder to Sandoz’s Emergency Motion to Stay. (Dkt. 366.)
On February 28, 2013, Sandoz filed Notice of Withdrawal of the Portion of Sandoz’s
Emergency Motion to Stay Requesting Alternative Relief Under Fed. R. Civ. P. Rule 60(b)(6).
(Dkt. 375.)

13
On February 28, 2013, Watson filed a Notice of Clarification and/or Partial Withdrawal of
14
15
16
17

Watson’s Notice and Joinder of Emergency Motion as to the Portion Requesting Alternative Relief
Under Fed. R. Civ. P. 60(b)(6). (Dkt. 376.)
In view of the Watson notice of withdrawal as well as the Sandoz notice of withdrawal, IT

18

IS HEREBY ORDERED that Watson’s motion pursuant to Fed. R. Civ. P. 60(b)(6) is hereby

19

DENIED as moot.

20

DATED this 8th day of March 2013.

21
22
________________________________
Kent J. Dawson
United States District Judge

23
24
25
26
27
28
29
2